LDK-378 dihydrochloride(Ceritinib dihydrochloride)

• Catalog Number: orb1089555
• Category: Small Molecules
• Description: Ceritinib, also known as LDK-378, is a selective inhibitor of ALK1, a target found in metastatic non-small cell lung cancer (NSCLC). In Phase I trials, LDK378 showed a marked clinical response in 78 patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during or after crizotinib therapy or had not been previously treated with crizotinib. LDK378 blocks the ALK protein and stops it sending growth signals to cancer cells, which may stop them growing. Ceritinib was approved in April 2014.
• CAS Number: [1380575-43-8]
• MW: 631.0570226
• SMILES: Cl.Cl.CC1=C(C2CCNCC2)C=C(OC(C)C)C(NC2=NC=C(Cl)C(NC3=C(S(C(C)C)(=O)=O)C=CC=C3)=N2)=C1
• Formula: C₂₈H₃₈CL₃N₅O₃S
• Note: For research use only
• Expiration Date: 12 months from date of receipt.